Recent advances in the treatment of acute leukemia: 1999
Data up to Jan 2025
Total Citations Per Year
Abstract
References (32)
The Importance of Diagnostic Cytogenetics on Outcome in AML: Analysis of 1,612 Patients Entered Into the MRC AML 10 Trial
1998 • 2,668 citations
Use of Arsenic Trioxide (As2O3 ) in the Treatment of Acute Promyelocytic Leukemia (APL): II. Clinical Efficacy and Pharmacokinetics in Relapsed Patients
1997 • 1,431 citations
Complete Remission after Treatment of Acute Promyelocytic Leukemia with Arsenic Trioxide
1998 • 1,220 citations
A Randomized Comparison of All Transretinoic Acid (ATRA) Followed by Chemotherapy and ATRA Plus Chemotherapy and the Role of Maintenance Therapy in Newly Diagnosed Acute Promyelocytic Leukemia
1999 • 748 citations
Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype.
1998 • 699 citations
Arsenic Trioxide Selectively Induces Acute Promyelocytic Leukemia Cell Apoptosis Via a Hydrogen Peroxide-Dependent Pathway
1999 • 539 citations
Therapeutic Targeting of Transcription in Acute Promyelocytic Leukemia by Use of an Inhibitor of Histone Deacetylase
1998 • 517 citations
A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RARalpha-positive acute promyelocytic leukemia. PETHEMA group.
1999 • 420 citations
Arsenic Trioxide as an Inducer of Apoptosis and Loss of PML/RARα Protein in Acute Promyelocytic Leukemia Cells
1998 • 355 citations
Prospective Karyotype Analysis in Adult Acute Lymphoblastic Leukemia: The Cancer and Leukemia Group B Experience
1999 • 312 citations
Minimal Residual Disease Status Before Allogeneic Bone Marrow Transplantation Is an Important Determinant of Successful Outcome for Children and Adolescents With Acute Lymphoblastic Leukemia
1998 • 259 citations
Protracted and Variable Latency of Acute Lymphoblastic Leukemia AfterTEL-AML1 Gene Fusion In Utero
1999 • 255 citations
Rapid activation of MDR1 gene expression in human metastatic sarcoma after in vivo exposure to doxorubicin.
1999 • 230 citations
Arsenic Trioxide and Melarsoprol Induce Programmed Cell Death in Myeloid Leukemia Cell Lines and Function in a PML and PML-RAR Independent Manner
1998 • 228 citations
Arsenic targets tubulins to induce apoptosis in myeloid leukemia cells.
1999 • 208 citations
Adult Patients With De Novo Acute Myeloid Leukemia and t(9; 11)(p22; q23) Have a Superior Outcome to Patients With Other Translocations Involving Band 11q23: A Cancer and Leukemia Group B Study
1997 • 184 citations
Expression of chromosome 21-localized genes in acute myeloid leukemia: differences between Down syndrome and non-Down syndrome blast cells and relationship to in vitro sensitivity to cytosine arabinoside and daunorubicin.
1999 • 180 citations
Treatment of Refractory and Relapsed Acute Myelogenous Leukemia With Combination Chemotherapy Plus the Multidrug Resistance Modulator PSC 833 (Valspodar)
1999 • 152 citations
Treatment of Refractory and Relapsed Acute Myelogenous Leukemia With Combination Chemotherapy Plus the Multidrug Resistance Modulator PSC 833 (Valspodar)
1999 • 122 citations
Acute promyelocytic leukemia: a curable disease
1998 • 121 citations
Childhood Acute Lymphoblastic Leukemia With the MLL-ENL Fusion and t(11;19)(q23;p13.3) Translocation
1999 • 111 citations
Hyperdiploid Acute Lymphoblastic Leukemia With 51 to 65 Chromosomes: A Distinct Biological Entity With a Marked Propensity to Undergo Apoptosis
1999 • 104 citations
Parallel Phase I Studies of Daunorubicin Given With Cytarabine and Etoposide With or Without the Multidrug Resistance Modulator PSC-833 in Previously Untreated Patients 60 Years of Age or Older With Acute Myeloid Leukemia: Results of Cancer and Leukemia Group B Study 9420
1999 • 89 citations
Complete Remission of t(11;17) Positive Acute Promyelocytic Leukemia Induced by All-trans Retinoic Acid and Granulocyte Colony-Stimulating Factor
1999 • 83 citations
Treatment of therapy-refractory B-lineage acute lymphoblastic leukemia with an apoptosis-inducing CD19-directed tyrosine kinase inhibitor.
1999 • 80 citations
Cytogenetic abnormalities associated with the t(12;21): a collaborative study of 169 children with t(12;21)-positive acute lymphoblastic leukemia
1999 • 79 citations
The leukemogenic fusion of MLL with ENL creates a novel transcriptional transactivator
1999 • 45 citations
Clonal stability in children with acute lymphoblastic leukemia (ALL) who relapsed five or more years after diagnosis
1999 • 40 citations
Anti-CD19 antibodies inhibit the function of the P-gp pump in multidrug-resistant B lymphoma cells.
1999 • 32 citations
Inv(16) acute myeloid leukemia cells show an increased sensitivity to cytosine arabinoside in vitro
1998 • 26 citations
Book Review Clone: The road to Dolly, and the path ahead By Gina Kolata. 276 pp. New York, William Morrow, 1998. $23. 0-688-15692-4 Remaking Eden: Cloning and beyond in a brave new world By Lee M. Silver. 317 pp. New York, Avon Books, 1997. $25. 0-380-97494-0
1998 • 2 citations
True
1999 • 2 citations